Author

Kei Fong Lam

Hong Kong Baptist UniversityORCID 0000-0002-1891-8624Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:machine learning (classical)· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Aiping LüiD· 1 shared Chaochao Zheng· 1 shared Daogang GuaniD· 1 shared Debajyoti ChowdhuryiD· 1 shared Hailong ZhuiD· 1 shared Hiu Fung YipiD· 1 shared Kexin WangiD· 1 shared Liang LaniD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Aiping LüORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ReDisX: a Continuous Max Flow-based framework to redefine the diagnosis of diseases based on identified patterns of genomic signatures

Hiu Fung Yip, Debajyoti Chowdhury, Kexin Wang, Yujie Liu, Yao Gao, Liang Lan, Chaochao Zheng, Daogang Guan, Kei Fong Lam, Hailong Zhu, Xue‐Cheng Tai, Aiping Lü

ReDisX redefines disease diagnosis by classifying patients based on genomic signatures, revealing disease subpopulations and identifying GZMB as a potential drug repurposing marker.

bioRxiv · Apr 11, 2022 · PreprintBioinformatics